- Lipid-lowering therapy in selected specific groups of patients2020 | Third Faculty of Medicine
- Combined lipid-lowering therapy: where we are and where we are going2015 | First Faculty of Medicine
- The importance of lipid-lowering therapy2011 | First Faculty of Medicine
- What will the lipid-lowering therapy in 2014?2014 | First Faculty of Medicine
- Stroke prevention by lipid lowering therapy2009 | First Faculty of Medicine
- Modern trends of lipid-lowering therapy +1Publication without faculty affiliation
- Opinion on the new advanced lipid-lowering therapy2015 | First Faculty of Medicine
- The effect of lipid - lowering therapy on endothelial dysfunction and non - lipid risk factors of atherosclerosisPublication without faculty affiliation
- Lipid lowering therapy increases heart rate variability in subjects with combined hyperlipidemiaPublication without faculty affiliation
- Indication of lipid-lowering therapy in a „statin-intolerant“ patient2009 | First Faculty of Medicine
- Aortic stenosis and results of the SEAS study - Does lipid-lowering therapy of aortic stenosis make any sense?2009 | Publication without faculty affiliation
- Correlation of lipoprotein (a) concentration with the extent of coronary artery disease in patients on lipid lowering therapy2012 | Third Faculty of Medicine
- Regression of coronary atherosclerosis and plaque composition changes during lipid-lowering therapy2012 | First Faculty of Medicine, Faculty of Education
- Adverse reactions during extracorporeal lipid lowering therapy in familial hyperlipoproteinaemiaPublication without faculty affiliation
- Morphological and functional impact of intensive lipid lowering therapy upon the course of atherosclerosis2004 | Faculty of Medicine in Hradec Králové
- The impact of aggressive lipid lowering therapy upon cholesterol biosynthesis and absorption2002 | Faculty of Medicine in Hradec Králové
- Lipid lowering therapy - proven treatment options and prospects for the near future2022 | First Faculty of Medicine
- Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy2012 | First Faculty of Medicine
- Levels of circulating matrix-metallproteinases and the effect of lipid-lowering therapy in patients with hypercholesterolemiaPublication without faculty affiliation
- Lipid-lowering therapy has beneficial effect on large artery stiffness in combined hyperlipidaemia +1Publication without faculty affiliation
- Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study2021 | First Faculty of Medicine
- Thrombocyte aggregation after lipid lowering therapy by selective LDL-apheresis in familial hyperlipoproteinemiaPublication without faculty affiliation
- Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)2021 | First Faculty of Medicine
- Current trends, news and developments in lipid-lowering therapy in terms of individual groups of pharmaceuticals, their combinations and new technologies2012 | Faculty of Medicine in Hradec Králové
- Secondary dyslipidaemia - overview for general practitioners2019 | First Faculty of Medicine
- Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology2017 | First Faculty of Medicine, Faculty of Education
- Are there caveats in a treatment of CAD?2018 | First Faculty of Medicine
- The beneficial effect of four-year lipid-lowering therapy on common carotid artery intimal thickness in patients with familial hyperlipo proteinaemias1998 | Faculty of Physical Education and Sport